Esophageal Precancer Testing Program Launched at Hoag
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Unknown Origin & Other Cancer Types |
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cardiovascular |
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Read MorePosted by Chris Wolski | Jun 18, 2025 | Cancer |
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Company News |
Access Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Read MorePosted by Chris Wolski | Jun 11, 2025 | Cancer |
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More